Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Adverse Drug Event

idarubicin has been researched along with Adverse Drug Event in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Abrahamsson, J; Forestier, E; Hasle, H; Heldrup, J; Jahnukainen, K; Jónsson, OG; Lausen, B; Palle, J; Zeller, B1
Brown, CA; Hashem, B; Lane, JE; Lesher, JL; Marzec, T1

Other Studies

4 other study(ies) available for idarubicin and Adverse Drug Event

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jan-20, Volume: 29, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Finland; Granulocyte Colony-Stimulating Factor; Humans; Iceland; Idarubicin; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Recombinant Proteins; Remission Induction; Risk Assessment; Scandinavian and Nordic Countries; Survival Analysis

2011
Pressure-induced bullae and sweat gland necrosis following chemotherapy induction.
    The American journal of medicine, 2004, Sep-15, Volume: 117, Issue:6

    Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Blister; Cytarabine; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Humans; Idarubicin; Leukemia, Myeloid; Male; Necrosis; Remission Induction; Sweat Gland Diseases; Sweat Glands

2004